Cargando…

The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer

AIM: To evaluate the impact of early re-resection on the incidence of tumour recurrence and progression in patients with pT1 high-grade non-muscle invasive bladder cancer (HG-NMIBC). PATIENTS AND METHODS: From 2001 to 2008, 486 consecutive patients were diagnosed with pT1 HG-NMIBC. Data were collect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasdev, Nikhil, Dominguez-Escrig, Jose, Paez, Edgar, Johnson, Mark I, Durkan, Garrett C, Thorpe, Andrew C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436501/ https://www.ncbi.nlm.nih.gov/pubmed/22988482 http://dx.doi.org/10.3332/ecancer.2012.269

Ejemplares similares

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer
por: Herr, Harry W.
Publicado: (2011)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
por: Chhaya, Saachi, et al.
Publicado: (2023)

Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer
por: Peyton, Charles C., et al.
Publicado: (2018)

Laparoscopic partial nephrectomy: Technical considerations and an update
por: Dominguez-Escrig, Jose L, et al.
Publicado: (2011)

The Prognostic Value of Cell Cycle Gene Expression Signatures in Muscle Invasive, High-Grade Bladder Cancer
por: Dancik, Garrett M., et al.
Publicado: (2015)

Blue light transurethral resection and biopsy of bladder cancer with hexaminolevulinate: Histopathological characteristics and recurrence rates in a single UK centre study
por: Chan, Kimberley, et al.
Publicado: (2023)

Continent Urinary Diversion
por: Moon, Andrew, et al.
Publicado: (2013)

Metabolic complications of urinary intestinal diversion
por: Vasdev, Nikhil, et al.
Publicado: (2013)

Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
por: Eckstein, Markus, et al.
Publicado: (2021)

Immunotherapy for bladder cancer
por: Fuge, Oliver, et al.
Publicado: (2015)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2015)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Kwon, Dae Hyeon, et al.
Publicado: (2012)

The surgical management of the refractory overactive bladder
por: Vasdev, Nikhil, et al.
Publicado: (2010)

Biomarkers in Bladder Cancer Surveillance
por: Sugeeta, Sukumar S., et al.
Publicado: (2021)

Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer
por: D’Andrea, David, et al.
Publicado: (2021)

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer
por: Sawasdee, Anupong, et al.
Publicado: (2022)

Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2018)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Re: Factors affecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG
por: Huang, Haichao, et al.
Publicado: (2014)

AB180. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2016)

High-Grade Non-Muscle Invasive Bladder Cancer: When to Move to Early Radical Cystectomy?
por: Azhar, Raed A, et al.
Publicado: (2021)

Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians
por: Ślusarczyk, Aleksander, et al.
Publicado: (2021)

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
por: Azawi, Nessn, et al.
Publicado: (2023)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
por: Li, Longchao, et al.
Publicado: (2023)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
por: Taskovska, Milena, et al.
Publicado: (2020)

Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC)
por: Bilim, Vladimir, et al.
Publicado: (2022)

Review of the evidence for robotic-assisted robotic cystectomy and intra-corporeal urinary diversion in bladder cancer
por: Brodie, Andrew, et al.
Publicado: (2020)

Current Strategies to Enhance Recovery following Radical Cystectomy: Single Centre Initial Experience
por: Vasdev, Nikhil, et al.
Publicado: (2012)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2021)

Prognostic nomogram for estimating survival in patients with resected muscle-invasive bladder cancer receiving chemotherapy
por: Hu, Bing, et al.
Publicado: (2023)

MicroRNA Expression Profile Identifies High Grade, Non-Muscle-Invasive Bladder Tumors at Elevated Risk to Progress to an Invasive Phenotype
por: Lenherr, Sara M., et al.
Publicado: (2017)

Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
por: Arianayagam, Ranjan, et al.
Publicado: (2018)

The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer
por: Soria, Francesco, et al.
Publicado: (2019)

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer
por: Gill, Tejpal S., et al.
Publicado: (2014)

Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer
por: Moran, George W., et al.
Publicado: (2017)

Oscillations of skyrmion clusters in Co/Pt multilayer nanodots
por: Tejo, Felipe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_th5m9qd8l22a74va1f1t0r3ajk